Executive Summary
The September 21, 2026, MCA Merger & Acquisition Tracker reveals a market actively restructuring through both inorganic expansion and strategic divestitures, with a clear tilt towards high-growth sectors like renewable energy, aerospace & defence, and healthcare services.
A dominant theme is the use of wholly-owned subsidiaries and LLPs for targeted entry into new verticals, as seen with Shekhawati Industries (solar), Share India Securities (wealth management), and Ather Energy (APAC procurement). The period-over-period data highlights a stark contrast between early-stage acquisitions (Zodiac Energy's Zenwatt, with negligible turnover) and revenue-accretive deals (Rays of Belief's CPG, with $11.43M revenue), underscoring varying risk profiles. Notably, insider activity is absent across all filings, but capital allocation decisions—from IPO proceeds deployment (Purple Style Labs) to complex share swaps (Kapil Raj Finance) and a significant divestiture (Thyrocare)—signal a market in flux. The most critical developments are the Himadri Speciality Chemical demerger, which creates a pure-play tyre value chain play, and Samvardhana Motherson's entry into defence-grade connectors, a high-barrier, high-growth niche. The portfolio-level pattern is one of strategic realignment: companies are shedding non-core assets (Thyrocare) while aggressively building capabilities in future-facing industries, creating a bifurcated opportunity set for investors.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: M&A
Tracking the trend? Catch up on the prior India Merger Acquisition MCA Regulatory Filings digest from September 19, 2026.
Investment Signals (9)
- Samvardhana Motherson International (SAMIL) (BULLISH)▲
Acquiring 50.1% of Rotary Connectors (defence connectors) for an EV of INR 5,004 Mn. RCPL's revenue grew 20.1% YoY (FY26: INR 1,235 Mn vs FY25: INR 1,028 Mn) and 64.2% over two years (FY24: INR 752 Mn), showing strong, compounding growth in a high-moat sector. Promoters retaining 49.9% aligns interests.
- Rays of Belief Ltd (Mom's Belief) ↓ (BULLISH)▲
Completed acquisition of 100% of City Pro Group (CPG), a profitable US pediatric healthcare provider with FY25 revenue of US$11.43 Mn (~₹97.27 Cr). This is immediately revenue-accretive (vs. FY26 EPS of ₹3.21) and provides a two-way India-US capability exchange, a unique cross-border healthcare model.
- Himadri Speciality Chemical Ltd (HSCL) (BULLISH)▲
Approved demerger of Dalmia Bharat Refractories' tyre business (turnover INR 149.31 Cr) into HSCL. This creates vertical integration synergies with HSCL's carbon black operations, potentially improving margins. The zero-cash, share-swap structure is tax-efficient and aligns long-term incentives.
- Race Eco Chain Limited ↓ (BULLISH)▲
Received 'no adverse observations' from BSE/NSE for its composite scheme to demerge its Biomass and Restore Bag divisions into two separate listed entities. This unlocks hidden value by creating pure-play, focused companies, potentially leading to a valuation re-rating for each entity.
- Shekhawati Industries Limited ↓ (BULLISH)▲
Board approved a 69% stake in a new solar/green energy LLP. This is a significant pivot into a high-growth sector (renewable energy) with potential for operational synergy, though execution risk remains as the entity is proposed.
-
Divesting 100% of Nueclear Healthcare (NHL) for ₹141.40 Cr (cash + CCPS). While NHL's FY26 PAT margin was 10.9% on ₹44.62 Cr turnover (5.38% of consolidated), the sale allows Thyrocare to focus on its core, higher-margin pathology business, improving overall RoCE. [NEUTRAL to BULLISH]
- Kapil Raj Finance Ltd. ↓ (MIXED)▲
Acquiring 90% of Henyo Pack via a massive share swap (100:1 ratio) and increasing authorized capital 4.2x (from ₹11 Cr to ₹46 Cr). This is a transformative reverse-merger-like event, but Henyo's turnover declined 39.3% YoY (FY25: ₹4,673 Lakh vs FY24: ₹2,836 Lakh), raising concerns about the quality of the asset being acquired.
- Zodiac Energy Limited ↓ (NEUTRAL)▲
Completed acquisition of 63.5% in Zenwatt Clean Energy (BESS). Zenwatt had nil turnover for two years and only ₹5.13 Lakh in FY26, indicating a very early-stage, high-risk/high-reward bet on the Battery Energy Storage market.
- Share India Securities Limited ↓ (BULLISH)▲
Approved ₹200 Cr preferential warrant issue and ₹120 Cr for a new wealth management subsidiary. This signals aggressive capital raising for expansion into a high-fee, asset-light business (wealth management), which could significantly boost RoE if executed well.
Risk Flags (8)
- Kapil Raj Finance / Acquisition Quality↓ [HIGH RISK]▼
Henyo Pack's turnover dropped sharply from ₹4,673.38 Lakh (FY24) to ₹2,836.41 Lakh (FY25), a 39.3% decline. Acquiring a 90% stake in a shrinking business via a highly dilutive share swap (100:1) poses significant integration and value destruction risk for existing shareholders.
- Thyrocare Technologies / Counterparty Risk↓ [HIGH RISK]▼
The buyer, Trovera Healthcare, was incorporated on June 16, 2026, and has no audited financials. Accepting a significant portion of the consideration (₹81.90 Cr out of ₹141.40 Cr) in CCPS of a newly incorporated, unproven entity introduces substantial credit and liquidity risk.
- Zodiac Energy / Early-Stage Risk↓ [MODERATE RISK]▼
Zenwatt Clean Energy, despite being incorporated in July 2023, had nil turnover for two years and only ₹5.13 Lakh in FY26. The 63.5% acquisition for ₹1.14 Cr is a bet on future BESS potential, but the target has zero revenue track record, making it a high-risk venture.
- Purple Style Labs / Regulatory Hurdle↓ [MODERATE RISK]▼
The USD 7M investment in its US subsidiary is contingent on approval from an authorized dealer bank under FEMA rules. Any delay or denial could stall the subsidiary's expansion plans, which are already funded by IPO proceeds (INR 530 Mn).
- Rays of Belief / Integration Risk↓ [MODERATE RISK]▼
Acquiring a 100% US-based pediatric healthcare provider (CPG) with operations across multiple New York locations. Cross-border healthcare integration, especially with state-specific regulations (NY Early Intervention Program, Medicaid), presents significant operational and compliance challenges.
- Race Eco Chain / Scheme Execution Risk↓ [MODERATE RISK]▼
The demerger is subject to multiple approvals (shareholders, NCLT, listing requirements). The observation letter is valid for only six months (until March 21, 2027). Any delay in obtaining approvals could cause the scheme to lapse, creating uncertainty for shareholders.
- ▼
While no cash is involved, HSCL will issue new shares to DBRL shareholders for the demerged tyre business (turnover only 3.39% of HSCL's total). This will cause slight dilution for existing HSCL shareholders for a relatively small asset, which may not be immediately accretive.
- Dixon Technologies / Pre-Revenue Subsidiary↓ [LOW RISK]▼
Incorporated a new subsidiary, Adivistar Electronics, which has nil turnover and has not commenced business. The ₹2.55 Cr investment is a start-up cost, and there is no immediate revenue or profit contribution expected.
Opportunities (8)
- Samvardhana Motherson / Defence Connectors Play↓ (OPPORTUNITY)◆
Acquiring 50.1% of Rotary Connectors (RCPL) at an EV/Revenue multiple of ~4.05x (FY26 revenue of INR 1,235 Mn). Given RCPL's 20%+ YoY revenue growth and military-grade product moat, this is a reasonable entry into a high-growth, high-barrier sector. Watch for Q4 FY27 closure.
- Race Eco Chain / Value Unlocking via Demerger↓ (OPPORTUNITY)◆
The composite scheme to list Biomass and Restore Bag divisions separately could unlock significant value. Pure-play companies in renewable energy (Biomass) and sustainable packaging (Restore Bag) often command higher multiples than a diversified conglomerate. Monitor shareholder meeting dates.
- Rays of Belief / Cross-Border Healthcare Arbitrage↓ (OPPORTUNITY)◆
Acquiring CPG (US$11.43M revenue) provides a platform to leverage India's lower-cost clinical talent for US patients, creating a unique margin expansion opportunity. The combined entity could become a leading player in the India-US pediatric healthcare corridor.
- ◆
The demerger of DBRL's tyre business into HSCL creates a vertically integrated model (carbon black to tyre). This can lead to cost savings, supply chain security, and potentially higher margins for the tyre business, making HSCL a more attractive long-term holding.
- Share India Securities / Wealth Management Foray↓ (OPPORTUNITY)◆
The ₹120 Cr investment in a new wealth management subsidiary, funded partly by a ₹200 Cr warrant issue, signals a strategic shift towards a high-RoE, fee-based business. If the subsidiary captures even a small market share, it could significantly boost the parent's consolidated profitability.
- Shekhawati Industries / Green Energy Pivot↓ (OPPORTUNITY)◆
Taking a 69% stake in a solar/green energy LLP is a decisive move into a sector with strong government tailwinds. As a related-party transaction at arm's length, it suggests management is confident in the opportunity. The LLP structure offers tax pass-through benefits.
- Thyrocare Technologies / Core Business Focus↓ (OPPORTUNITY)◆
The sale of NHL (5.38% of revenue) for ₹141.4 Cr provides a capital infusion. Thyrocare can use this to pay down debt, increase dividends, or invest in its core pathology business, which likely has higher margins and a stronger competitive position.
- Ather Energy / Supply Chain Resilience↓ (OPPORTUNITY)◆
Incorporating a Hong Kong subsidiary for APAC procurement is a strategic move to de-risk its supply chain. For a company reliant on battery and electronic components, this could lead to cost savings and better inventory management, indirectly boosting margins.
Sector Themes (5)
- Renewable Energy & Green Transition (THEME)◆
Three filings (Shekhawati Industries, Zodiac Energy, Race Eco Chain) are directly tied to the green energy theme—solar, BESS, and biomass. This indicates a strong corporate push into the sector, driven by policy support and ESG mandates. Investors should watch for similar moves from other mid-cap industrials.
- Strategic Divestitures for Core Focus (THEME)◆
Thyrocare's sale of Nueclear Healthcare is a textbook example of a company shedding a non-core subsidiary to sharpen focus on its main business. This trend of 'de-conglomeration' is gaining traction in Indian markets as companies seek to improve RoCE and valuation multiples.
- Cross-Border Expansion via Subsidiaries (THEME)◆
Both Purple Style Labs (US) and Rays of Belief (US) and Ather Energy (Hong Kong) are establishing or acquiring overseas entities. This reflects a growing confidence among Indian companies to expand globally, particularly in the US and APAC, to access new markets and capabilities.
- Value Unlocking via Demergers (THEME)◆
Race Eco Chain and Himadri Speciality Chemical are pursuing demergers to create focused, pure-play entities. This is a powerful catalyst for value creation, as it allows the market to assign appropriate multiples to distinct business lines, often leading to a re-rating of the sum-of-parts.
- Early-Stage, High-Risk Acquisitions (THEME)◆
Zodiac Energy's acquisition of a pre-revenue BESS company and Kapil Raj's acquisition of a declining packaging firm highlight a subset of deals where the risk is elevated. These are bets on future technology or turnaround stories, requiring deep due diligence and a high risk appetite from investors.
Watch List (7)
- Race Eco Chain↓ (WATCH)👁
Shareholder and NCLT approvals for the composite demerger scheme. The observation letter is valid until March 21, 2027. Any updates on the timeline will be a key catalyst.
- Himadri Speciality Chemical↓ (WATCH)👁
Regulatory approvals (stock exchanges, SEBI, NCLT) for the demerger of DBRL's tyre business. The appointed date is October 1, 2026. Monitor for any objections or delays.
- Samvardhana Motherson (Rotary Connectors) (WATCH)👁
Closure of the 50.1% acquisition, expected by Q4 FY26-27. Any updates on the locked box mechanism or due diligence findings will be material.
- Thyrocare Technologies↓ (WATCH)👁
Shareholder approval for the sale of Nueclear Healthcare and the subsequent receipt of consideration (cash + CCPS from Trovera). The completion date is November 30, 2026.
- Purple Style Labs↓ (WATCH)👁
Approval from the authorized dealer bank under FEMA for the USD 7M investment in its US subsidiary. Expected within 30 days of the filing (by ~Oct 21, 2026).
- Kapil Raj Finance↓ (WATCH)👁
Stock exchange approval for the share swap acquisition of Henyo Pack. The proposed completion is within 30 days of such approval. The massive increase in authorized capital is a key event to track.
- Zodiac Energy↓ (WATCH)👁
Integration of Zenwatt Clean Energy and any initial operational updates from the BESS business. Given Zenwatt's negligible revenue, any new order wins or project announcements will be a significant positive catalyst.
Filing Analyses
(14)
21-09-2026
Purple Style Labs Ltd's board approved a USD 7 million investment in its wholly owned US subsidiary, Purple Style Labs USA Inc., via the acquisition of 7 million Class B Common Stock. The investment will be primarily funded from IPO proceeds (INR 530 million) and used for the subsidiary's general corporate purposes. The subsidiary, which operates a Pernia's Pop-Up Studio retail experience in New York City, reported a turnover of INR 11.58 million (USD 11.58 million) for its first partial year of operations (April 2025–March 2026).
- · PSL USA was incorporated on April 16, 2025, as a Delaware Corporation.
- · PSL USA's share capital comprises 10,000,000 Class A Common Stock ($0.00001 par value each) and 2,000,000 Class B Common Stock ($1 par value each).
- · The investment requires approval from an authorized dealer bank under Foreign Exchange Management (Overseas Investment) Rules, 2022, with completion expected within 30 days of receiving that approval.
- · The transaction is considered a related party transaction (PSL USA is a wholly owned subsidiary) but is stated to be at arm's length and in line with IPO objects.
- · Promoter Abhishek Agarwal serves as President, Secretary and Treasurer of PSL USA.
21-09-2026
Shekhawati Industries Ltd's Board approved subscribing as a partner in the proposed Shekhawati New Energy LLP, with an investment of up to 69% stake. The investment is in the mega solar/green energy sector, is a related party transaction (at arm's length), and will be for cash consideration. The move aims to create operational synergy and expertise in renewable energy.
- · The investment is a related party transaction as directors are common in the entities.
- · The investment is for cash consideration.
- · The target entity, Shekhawati New Energy LLP, is a proposed professional renewable energy company focusing on solar and green energy solutions.
- · No governmental or regulatory approvals are required for the investment.
- · The indicative time period for completion is post incorporation of the LLP.
21-09-2026
Zodiac Energy Limited has completed the acquisition of a 63.5% majority equity stake in Zenwatt Clean Energy Private Limited, making it a subsidiary effective September 21, 2026. The acquisition, approved by the Board in February 2026, involves a cash consideration of ₹1,14,30,000 for 6,35,000 equity shares at ₹18 per share. Zenwatt, incorporated in July 2023, is engaged in Battery Energy Storage Systems (BESS) and reported a turnover of only ₹5,13,000 for FY 2025-26, with nil turnover in the prior two years, indicating it is a very early-stage entity.
- · The acquisition is a related party transaction as the Promoter and members of the Promoter Group have an interest in Zenwatt Clean Energy Private Limited, but it is stated to be at arm's length.
- · Zenwatt Clean Energy Private Limited was incorporated on July 7, 2023, and had nil turnover in FY 2023-24 and FY 2024-25, with only ₹5,13,000 turnover in FY 2025-26.
- · The acquisition was approved by the Board on February 9, 2026, and has now been completed.
21-09-2026
Ather Energy Limited has incorporated a wholly owned subsidiary, Ather Energy Hong Kong Limited, in Hong Kong on September 21, 2026, to support critical procurement functions and enhance supply chain resilience in the Asia-Pacific region. The subsidiary is 100% controlled by Ather Energy, with 16,50,000 ordinary shares subscribed at HKD 1 per share for cash consideration. No governmental or regulatory approvals were required for the incorporation.
- · The subsidiary is incorporated in Hong Kong, a jurisdiction outside India, indicating international expansion of procurement operations.
- · The incorporation is a cash consideration transaction, with no share swap or governmental/regulatory approvals required.
- · The subsidiary is wholly owned, giving Ather Energy 100% control, which may enhance operational flexibility in the APAC region.
21-09-2026
Dixon Technologies (India) Limited has incorporated a new subsidiary, Adivistar Electronics India Private Limited, and subscribed to 25,50,000 equity shares at par for a total cash consideration of ₹2,55,00,000 (₹2.55 Crore). The subsidiary, incorporated on 13th August 2026, will operate as an original equipment manufacturer (OEM) of electronic devices, including smartphones. This acquisition is a related-party transaction as Adivistar is a wholly-owned subsidiary of Dixon, but no promoter/group companies have any other interest in the entity.
- · Adivistar was incorporated on 13th August 2026 and has not yet commenced business; turnover is nil.
- · The acquisition is a related-party transaction as Adivistar is a subsidiary of Dixon; no promoter/group companies have any interest in the entity.
- · All requisite governmental/regulatory approvals for the acquisition have been obtained.
- · The subsidiary will focus on OEM manufacturing of electronic devices, including smartphones, in India.
21-09-2026
Rays of Belief Ltd (Mom's Belief) completed the acquisition of 100% of City Pro Group Inc. (CPG), a New York-based pediatric healthcare provider, through its wholly owned subsidiary Mom's Belief US Inc., effective September 18, 2026. The deal strengthens Mom's Belief's U.S. presence and creates a two-way India–U.S. capability exchange. While the acquisition adds a revenue-generating platform (CPG FY25 revenue of US$11.43 Mn / ~₹97.27 Cr), the combined scale is expected to significantly enhance consolidated revenue, though integration risks and regulatory approvals for cross-border practices remain.
- · CPG was founded in 1995 and operates in Bronx, Brooklyn, Manhattan and Long Island (Plainview).
- · CPG is an approved New York State Department of Health Early Intervention Program provider and a Medicaid-enrolled provider.
- · Rays of Belief FY26 EPS was ₹3.21.
- · The acquisition was completed through Mom's Belief US Inc., making CPG a step-down wholly owned subsidiary.
- · The acquisition is expected to create a two-way exchange of clinical and operating capabilities between CPG and Mom's Belief's 136-centre Indian network.
21-09-2026
Kapil Raj Finance Ltd. approved the acquisition of 90% of Henyo Pack Limited via a share swap, issuing up to 26,54,87,700 equity shares (face value ₹1 each) to Henyo's shareholders at a swap ratio of 100:1. The board also approved an increase in authorized share capital from ₹11,00,00,000 to ₹46,00,00,000, adoption of a new MOA, change in company name, and appointment of Santosh Rani as Whole-time Director. Henyo's turnover declined to ₹4,673.38 Lakh in FY 2024-25 from ₹2,836.41 Lakh in FY 2023-24, indicating a sharp drop, though the acquisition aims to diversify into the packaging segment.
- · Henyo Pack Limited was incorporated on 08/08/1997
- · The acquisition is proposed to be completed within 30 days from stock exchange approval
- · The swap ratio is 100:1 (100 equity shares of Kapil Raj for every 1 share of Henyo)
- · The company will issue up to 66,98,000 additional equity shares on preferential basis to 5 investors
- · The board approved appointment of Santosh Rani as Whole-time Director w.e.f. 21.09.2026
- · The company's authorized capital will increase from ₹11,00,00,000 to ₹46,00,00,000
- · Henyo Pack Limited's turnover declined from ₹2,986.62 Lakh in FY 2022-23 to ₹2,836.41 Lakh in FY 2023-24, a 5% drop
- · The acquisition is subject to shareholder approval at the ensuing AGM and other regulatory approvals
21-09-2026
Race Eco Chain Limited has received observation letters with 'no adverse observations' from BSE and NSE regarding its draft composite scheme of arrangement to demerge its Biomass Division into Geoeco Green Energy Limited (Resultant Company No. 1) and its Restore Bag Division into Race Gateway Limited (Resultant Company No. 2). The stock exchanges have conveyed their 'no objection' to the scheme, subject to compliance with various conditions including shareholder approvals, NCLT filing, and listing requirements. The scheme remains subject to applicable regulatory approvals, and the observation letter is valid for six months from September 21, 2026.
- · The observation letters were issued by BSE and NSE on September 21, 2026.
- · SEBI provided comments on the draft scheme via letter dated July 30, 2026, including compliance with Regulation 11 of SEBI LODR, disclosure of ongoing adjudication/recovery proceedings, and ensuring financials in the scheme are not more than 6 months old.
- · The scheme involves two demerged undertakings: Demerged Undertaking No. 1 (Biomass Division) to Geoeco Green Energy Limited, and Demerged Undertaking No. 2 (Restore Bag Division) to Race Gateway Limited.
- · The resultant companies (Geoeco and Gateway) must complete listing and commence trading within 60 days of receipt of the NCLT order.
- · The observation letter is valid for six months from September 21, 2026, within which the scheme must be submitted to NCLT.
- · The company must disclose the no-objection letter on its website within 24 hours of receipt.
- · The scheme is subject to compliance with all applicable provisions of the Companies Act, 2013, including obtaining creditor consent.
21-09-2026
Himadri Speciality Chemical Ltd (HSCL) approved a Scheme of Arrangement to demerge the Tyre Business of Dalmia Bharat Refractories Limited (DBRL) into HSCL, effective from the Appointed Date of 1 October 2026. The demerged undertaking had a turnover of INR 149.31 crore (3.39% of HSCL's total turnover) as of 31 March 2026. No cash consideration is involved; HSCL will issue new shares to DBRL shareholders, with the shareholding pattern expected to change slightly. The scheme is subject to regulatory approvals and is aimed at integrating the tyre business with HSCL's carbon black operations to create synergies and enhance strategic focus.
- · Appointed Date for the Scheme is 1 October 2026.
- · No cash consideration is involved in the Scheme; consideration is in the form of Resulting Company New Shares.
- · The shareholding pattern of the Demerged Company (DBRL) will not undergo any change.
- · The Scheme is subject to approvals from stock exchanges, SEBI, NCLT, and shareholders/creditors.
- · The Resulting Company's promoter shareholding is expected to decrease marginally from 52.49% to 52.47% post-scheme.
- · Fractional shares arising from the Scheme will be consolidated and issued to a trustee nominated by the Board.
- · The fairness opinion was issued by Jajodia Equity Advisors Services Limited (Merchant Banker) dated 20 September 2026.
- · The valuation report was issued by SSPA & Co, Chartered Accountants, dated 20 September 2026.
21-09-2026
Himadri Speciality Chemical Ltd (HSCL) has approved a Scheme of Arrangement to demerge the Tyre Business of Dalmia Bharat Refractories Limited (DBRL) into HSCL, with the demerged undertaking's turnover at INR 149.31 crore (3.39% of HSCL's total turnover). The transaction involves no cash consideration; instead, HSCL will issue new shares to eligible DBRL shareholders, subject to regulatory approvals. The demerger is expected to create synergies in the tyre value chain, but the shareholding pattern will change slightly, and the scheme is subject to approvals from stock exchanges, SEBI, NCLT, and shareholders.
- · Appointed Date for the scheme is 1 October 2026
- · No cash consideration is involved in the scheme
- · Resulting Company New Shares will be listed on BSE and NSE
- · Shareholding pattern of Demerged Company (DBRL) will not change
- · Fractional shares will be consolidated and issued to a trustee nominated by the Board
- · Fairness opinion dated 20 September 2026 issued by Jajodia Equity Advisors Services Limited
- · Valuation report dated 20 September 2026 issued by SSPA & Co
21-09-2026
Samvardhana Motherson International Limited (SAMIL) announced that its wholly owned subsidiary, Samvardhana Motherson Adsys Tech Limited (SMAST), will acquire a 50.1% equity stake in Rotary Connectors Private Limited (RCPL) for an enterprise value of INR 5,004 Million. RCPL, which manufactures military-grade circular connectors for the Aerospace and Defence sector, reported a turnover of INR 1,235 Million for FY 2026, up from INR 1,028 Million in FY 2025 and INR 752 Million in FY 2024, showing strong growth. The acquisition is expected to close by Q4 FY 2026-27 and will make RCPL an indirect subsidiary of SAMIL, with the promoters retaining a 49.9% stake.
- · The acquisition is a cash consideration deal with no governmental or regulatory approvals required.
- · Equity value will be determined as enterprise value plus net cash as on locked box date of March 31, 2026, with adjustments for leakage or cash withdrawal.
- · SMAST will have the right to appoint a majority of directors on RCPL's board.
- · RCPL was incorporated on December 8, 2005.
21-09-2026
Panorama Studios International Limited has executed an Assignment Agreement with Ultra Media and Entertainment Private Limited to acquire the dubbing rights of the film 'Anomie - The Equation of Death' in all Indian languages and dialects, excluding Tamil, Malayalam, Kannada, and Telugu. The acquisition expands Panorama's content library but financial terms were not disclosed.
- · The dubbing rights exclude Tamil, Malayalam, Kannada, and Telugu languages.
- · The agreement was executed on September 21, 2026.
- · The filing was made under Regulation 30 of the SEBI Listing Regulations.
21-09-2026
Thyrocare Technologies' Board approved the sale of its entire 100% stake in wholly owned subsidiary Nueclear Healthcare Limited (NHL) to Trovera Healthcare Private Limited for a total consideration of ₹141.40 Crore, comprising a cash component of ₹59.50 Crore and 42,500 CCPS of Trovera valued at ₹81.90 Crore. The transaction, which also includes the purchase of NHL's Gurugram and Hyderabad properties for ₹20.59 Crore, is subject to shareholder approval and is expected to complete by November 30, 2026. While the divestment allows Thyrocare to focus on its core pathology business, NHL's financial contribution is modest, with FY26 turnover of ₹44.62 Crore (5.38% of consolidated turnover) and a PAT margin of 10.9%.
- · NHL is a material wholly owned subsidiary; after sale, Thyrocare will cease control over NHL.
- · The transaction is a slump sale and not an amalgamation/merger.
- · Trovera was incorporated on June 16, 2026 and has no audited financials for the preceding three years.
- · The CCPS have a face value of ₹10 each and are issued at a premium of ₹14,000 per CCPS.
- · The acquisition of CCPS is conditional upon completion of the NHL sale, which requires shareholder approval via special resolution.
- · The purchase of NHL's properties is exclusive of stamp duty and registration charges.
- · The Board meeting commenced at 2:15 PM on September 21, 2026.
- · The transaction is not a related party transaction; Trovera is not a promoter group company.
- · Expected completion date is on or before November 30, 2026, subject to conditions precedent.
Get daily alerts with 9 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 14 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Merger Acquisition MCA Regulatory Filings
September 18, 2026
India Merger Acquisition MCA Regulatory Filings — September 18, 2026
September 14, 2026
India Merger Acquisition MCA Regulatory Filings — September 14, 2026
September 13, 2026
India Merger Acquisition MCA Regulatory Filings — September 13, 2026
September 12, 2026
India Merger Acquisition MCA Regulatory Filings — September 12, 2026
🇮🇳 More from India
View all →September 21, 2026
India Upcoming Corporate Actions BSE NSE — September 21, 2026
India Upcoming Corporate Actions BSE NSE
September 21, 2026
India Pre-Market Regulatory Roundup — September 21, 2026
India Pre-Market Regulatory Roundup
September 21, 2026
India Quarterly Results BSE NSE Announcements — September 21, 2026
India Quarterly Results BSE NSE Announcements
September 21, 2026
India AGM EGM Shareholder Meeting Schedule — September 21, 2026
India AGM EGM Shareholder Meeting Schedule